Daniel Molloy-Brookes

Healthcare innovation is often associated with breakthrough medicines, advanced diagnostics and cutting-edge medical devices. Yet one of the most significant developments in recent years has emerged through software. Digital therapeutics, […]

The development of gene editing technologies has marked a significant shift in the way diseases are understood and potentially treated. Among these innovations, CRISPR has emerged as one of the […]

Why supply chains matter in life sciences The life sciences sector relies on complex, interconnected supply chains to deliver medicines, diagnostics and medical technologies to patients. From raw materials and […]

Digital health at a turning point Digital health has moved from the margins of healthcare innovation to the centre of strategic planning across the UK. The growing use of digital […]

Originally by: Amy Grove, Professor of Implementation Science, University of Birmingham Read the original here: https://www.linkedin.com/pulse/from-proof-concept-impact-how-implementation-tc3le/?trackingId=5d7TGbesSN%2BEqMkIJFR7Vg%3D%3D How do we ensure that innovations developed in health, education or social care make […]

The government’s new 10 Year Health Plan, Fit for the Future, was published on 3 July 2025. Heralded as a bold statement of intent, it promises three radical shifts: hospital […]

Aston University has announced a major international partnership with Max Healthcare India, one of the country’s largest and most respected hospital networks. The two organisations have signed a memorandum of […]

The UK government’s renewed focus on data-driven innovation in the life sciences sector marks a major shift in how health research, diagnostics and treatment are delivered. Central to this transformation […]

A major pillar of the UK government’s new Life Sciences Sector Plan is a bold drive to boost domestic manufacturing of medical products, underpinned by a commitment of up to […]

The UK government has launched a new Life Sciences Sector Plan, a ten-year strategy designed to boost the country’s position as a global leader in life sciences. Announced on Wednesday […]

Joenja was approved by the MHRA in 2024 but was only issued to patients on the NHS for the first time in June.  What is APDS?  APDS (activated phosphoinositide 3-kinase […]

Researchers have found a way to absorb a toxic and long-lasting “forever chemical” which is often used in consumer goods.  Used in various consumer products  Products such as waterproof clothing, […]

In a landmark move that places the UK at the forefront of international health innovation, the country has become the first to join a new global network of regulators dedicated […]

An $11bn partnership between BioNTech and Bristol Myers Squibb has been signed. Potential competition to a leading drug The partnership involves the development of a cancer drug which could, potentially, […]

Medilink Midlands welcomed some of the region’s most innovative and interesting life sciences and health tech companies to their annual awards evening at the Grand Station in Wolverhampton on Thursday. […]